Pasadena Villa Outpatient Expands Mental Health Care With New Outpatient Clinic in Lansing, Michigan
BRENTWOOD, TN / ACCESSWIRE / November 12, 2024 / Odyssey Behavioral Healthcare, a leading provider of high-quality mental health treatment...
Day: November 12, 2024
Bemax Inc. Retires Over Two Hundred Million Common Shares of Company Stock, Reduce Issued and Outstanding Shares.
Current total issued and outstanding shares reduced by 40.90%Dallas, Georgia--(Newsfile Corp. - November 12, 2024) - Bemax Inc. (OTC Pink:...
Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
NDA for CARDAMYST™ in PSVT under review by FDA; PDUFA March 27, 2025MONTREAL and CHARLOTTE, N.C., Nov. 12, 2024 (GLOBE...
Visory Health Breaks Barriers
The health tech company’s new app delivers healthcare in Spanish, boosting accessibility for millions in AmericaST. LOUIS, Nov. 12, 2024...
Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based...
Philips Spectral CT 7500 RT, world’s first spectral 4DCT respiratory-gated imaging receives FDA 510(k) clearance
Philips Spectral CT 7500 RT Spectral CT 7500 RT clinical November 12, 2024 Designed specifically for use in radiation oncology,...
Be There for Men this November
8 of 11 daily suicides are by men who are meant to be hereContent warning: This story contains content about...
Stride Autism Centers Appoints Emily Patrizi as Chief Operating Officer
Leading Company Focused on ABA Therapy for Preschool Children with Autism Expands Leadership TeamCHICAGO, Nov. 12, 2024 (GLOBE NEWSWIRE) --...
Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting
-Abstract Highlights New Preclinical Data on Exosome-Based Delivery of PMOs for the Treatment of DMD-SAN DIEGO, Nov. 12, 2024 (GLOBE...
Vincerx Pharma Reports Third Quarter 2024 Financial Results
Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC); additional data...
JenaValve Presents ALIGN-AR 2-Year Follow-Up Data at TCT 2024 and Announces Commencement of ARTIST Randomized Controlled Trial (RCT)
IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve...
Shineco Announces Reverse Split to Regain NASDAQ Compliance
BEIJING, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic...
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
BERKELEY, Calif. and MAINZ, Germany, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),...
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq
November 12, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq Biodexa Pharmaceuticals PLC,...
OneMedNet Announces Continued Investment into Bitcoin
MINNEAPOLIS, Nov. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a pioneer in curating regulatory-grade...
Palisade Bio Reports Third Quarter 2024 Financial Results and Outlines Key Accomplishments and Next Steps to Advance Lead Program PALI-2108
Commenced enrollment and dosing in Phase 1 clinical study of PALI-2108 for the treatment of moderate-to-severe Ulcerative Colitis (UC) Carlsbad, CA,...
Mustang Bio Receives Positive Listing Determination from Nasdaq
WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical...
Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
ROSELAND, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,...
Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update
Company accelerated commercialization with significant new partnerships both in the U.S. and EuropeATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Femasys...
Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to MedRxiv and BioRxiv, Respectively
CANOPY manuscript preprint includes six-month off-drug follow-up period that highlighted strong protection by pemivibart versus placebo in the immunocompetent Cohort...